Tissue factor pathway inhibitor (TFPI) in normal, IGT, and NIDDM subjects

被引:0
|
作者
Wolffenbuttel, BHR
Stolk, RP
vanOerle, R
Hamulyak, K
Grobbee, DE
Leurs, PB
机构
[1] UNIV LIMBURG HOSP,DEPT INTERNAL MED,MAASTRICHT,NETHERLANDS
[2] ERASMUS UNIV ROTTERDAM,SCH MED,DEPT EPIDEMIOL & BIOSTAT,NL-3000 DR ROTTERDAM,NETHERLANDS
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:899 / 899
页数:1
相关论文
共 50 条
  • [31] Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction
    Ye, ZY
    Takano, R
    Hayashi, K
    Ta, TV
    Kato, H
    Kamikubo, Y
    Nakahara, Y
    Kumeda, K
    Hara, S
    THROMBOSIS RESEARCH, 1998, 89 (06) : 263 - 270
  • [32] THE RATIO OF PHOSPHOLIPID TO TISSUE FACTOR MODULATES THROMBIN GENERATION IN PLASMA BY TISSUE FACTOR PATHWAY INHIBITOR (TFPI)
    GOODWIN, C
    LUPU, C
    SCULLY, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1186 - 1186
  • [33] SITES OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) AND TISSUE FACTOR EXPRESSION UNDER PHYSIOLOGICAL AND PATHOLOGICAL CONDITIONS
    OSTERUD, B
    BAJAJ, MS
    BAJAJ, SP
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (05) : 873 - 875
  • [34] Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI)
    Xu, XY
    Takano, R
    Nagai, Y
    Yanagida, T
    Kamei, K
    Kato, H
    Kamikubo, Y
    Nakahara, Y
    Kumeda, K
    Hara, S
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2002, 30 (3-4) : 151 - 160
  • [35] Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis
    Cella, G
    Vertolli, U
    Naso, A
    Vianello, A
    Rampin, E
    Sbarai, A
    Boeri, G
    Strauss, WE
    THROMBOSIS RESEARCH, 1996, 81 (06) : 671 - 677
  • [36] Tissue factor pathway inhibitor (TFPI) in patients with sepsis receiving prophylactic enoxaparin
    Abdelgadir, A. M.
    Al Otair, Hadeel A.
    Khurshid, Syed M.
    Alzeer, Abdul Aziz A.
    Al Momen, Abdul Kareem
    Al Shaikh, Mashael
    Al Gahtani, Farja
    Al Assiri, Zuhair
    Abdelrazik, Hossam A. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 25 - 26
  • [37] A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
    Dahm, AEA
    Andersen, TO
    Rosendaal, F
    Sandset, PM
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (04) : 651 - 658
  • [38] Increased tissue factor pathway inhibitor (TFPI) activity and coagulation in IDDM patients
    Leurs, PB
    vanOerle, R
    Wolffenbuttel, BHR
    Hamulyak, K
    DIABETOLOGIA, 1996, 39 : 898 - 898
  • [39] Interactions of plasmin with tissue factor pathway inhibitor (TFPI) in a mouse model of endotoxemia
    Lupu, F.
    Herlea, O.
    N, Popescu, I
    Tang, H.
    Lupu, C.
    Esmon, C. T.
    Lijnen, H. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 289 - 289
  • [40] Measurement of plasma and platelet tissue factor pathway inhibitor (TFPI) in blood donors
    Ellery, P.
    Augustsson, C.
    Maroney, S.
    Wood, J.
    Peterson, L.
    Hilden, I
    Mast, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 61 - 61